The Latest Cardiac and Vascular News
TORONTO, July 29, 2021 /PRNewswire/ – Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution. The new solution includes the world’s first 3-in-1 RF wire paired with a seamless shapeable dilator designed to optimize tissue dilation for large sheath procedures, including left atrial appendage closure, transvenous mitral valve repair, radiofrequency ablation, and […]
TORONTO, Jan. 23, 2020 /PRNewswire/ – A study has found that use of Baylis Medical’s SureFlex Steerable Guiding Sheath results in greater contact force stability for radiofrequency ablations in pulmonary vein isolations. Stable contact force has been linked to more effective ablations, a therapy in which radiofrequency energy is used to create a lesion in cardiac tissue to […]
TORONTO, Nov. 20, 2019 /PRNewswire/ – Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped wire, which acts as both puncture device and exchange rail. The puncture wire features Baylis’ signature RF puncture technology, […]
TORONTO, Oct. 31, 2019 /PRNewswire/ – Baylis Medical announced today the first North American use of its EPstar™ Fixed Electrophysiology Catheters. The EPstar catheters make available the smallest diagnostic catheter in the North American electrophysiology market, allowing physicians to reach previously inaccessible areas of the heart for procedure mapping. The EPstar catheter family includes a 2F […]
TORONTO, Sept. 23, 2019 /PRNewswire/ – Baylis Medical announced today the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution. The VersaCross solution is the world’s first all-in-one left-heart access device featuring an atraumatic RF-tipped pigtail wire. The device is designed to achieve left-heart access with controlled precision, while reducing the number of exchanges throughout the […]
TORONTO, May 2, 2019 /PRNewswire/ – Baylis Medical announced today the U.S. launch and first clinical use of its ExpanSure™ Transseptal Dilation System, used in a left-atrial appendage (LAA) closure case performed at the Cleveland Clinic, in Cleveland, Ohio. The ExpanSure dilator combines a sheath and dilator into a single tool, and facilitates larger dilation compared to a standard […]
TORONTO, Jan. 30, 2019 /PRNewswire/ – Baylis Medical is pleased to announce that seasoned marketing executive Gloria Yee has joined Baylis as its Vice President of Marketing. In her role, Gloria will be instrumental in expanding the company’s global commercialization strategy. “We are thrilled to welcome Gloria to Baylis,” said Baylis President Kris Shah. “Her demonstrated track record of setting and […]
TORONTO, Sept. 10, 2018 /PRNewswire/ – Baylis Medical Company, a leader in the development, manufacturing and commercialization of cardiology devices, announced the official commercial launch of its SureFlex® Steerable Guiding Sheath. The SureFlex sheath is part of Baylis’ rapidly growing portfolio of high-performance products for transseptal access. The sheath features an advanced sheath-to-dilator design for controlled crossing of […]
TORONTO, May 8, 2018 /PRNewswire/ – A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG® radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40% lower incidence of silent acute cerebral embolism in atrial fibrillation (AF) ablation procedure patients.1 The study publication follows a consensus statement recently revised by […]
